Cargando…
Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies
Despite the many therapeutic options available today for the treatment of hypertension, a sizable number of patients still remain resistant to treatment. The prevalence of resistant hypertension in the general population under optimal conditions is about 3–5%. Although several factors and conditions...
Autores principales: | Papademetriou, Vasilios, Tsioufis, Konstantinos, Gradman, Alan, Punzi, Henry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124360/ https://www.ncbi.nlm.nih.gov/pubmed/21822477 http://dx.doi.org/10.4061/2011/438198 |
Ejemplares similares
-
Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2011) -
Pathophysiology of Resistant Hypertension: The Role of Sympathetic Nervous System
por: Tsioufis, Costas, et al.
Publicado: (2011) -
Benefits from Treatment and Control of Patients with Resistant Hypertension
por: Doumas, Michael, et al.
Publicado: (2010) -
Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2011) -
New data, new studies, new hopes for renal denervation in patients with uncontrolled hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2019)